Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Guenter Kraus"'
Autor:
Katie Amssoms, Philip A Born, Max Beugeling, Ben De Clerck, Ellen Van Gulck, Wouter L J Hinrichs, Henderik W Frijlink, Niels Grasmeijer, Guenter Kraus, Roger Sutmuller, Kenny Simmen, Lieven Baert
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0202961 (2018)
A single-injection vaccine formulation that provides for both a prime and a boost immunization would have various advantages over a multiple-injection regime. For such a vaccine formulation, it is essential that the booster dose is released after a c
Externí odkaz:
https://doaj.org/article/39d9cf7d09974343b19898981fbcf509
Autor:
Max Beugeling, Katie Amssoms, Freek Cox, Ben De Clerck, Ellen Van Gulck, Jeroen A. Verwoerd, Guenter Kraus, Dirk Roymans, Lieven Baert, Henderik W. Frijlink, Wouter L. J. Hinrichs
Publikováno v:
Pharmaceutics, Vol 11, Iss 10, p 510 (2019)
Currently, there is an increasing interest to apply pre-fusion (pre-F) protein of respiratory syncytial virus (RSV) as antigen for the development of a subunit vaccine. A pre-F-containing powder would increase the flexibility regarding the route of a
Externí odkaz:
https://doaj.org/article/1fab9f6aa5144ad296de6c6ca8e08c85
Autor:
Martina Kovarova, Olivia D Council, Abhijit A Date, Julie M Long, Tomonori Nochi, Michael Belshan, Annemarie Shibata, Heather Vincent, Caroline E Baker, William O Thayer, Guenter Kraus, Sophie Lachaud-Durand, Peter Williams, Christopher J Destache, J Victor Garcia
Publikováno v:
PLoS Pathogens, Vol 11, Iss 10, p e1005170 (2015)
Externí odkaz:
https://doaj.org/article/daf07c6ade6b4232b93e54a9a07d886a
Autor:
Martina Kovarova, Olivia D Council, Abhijit A Date, Julie M Long, Tomonori Nochi, Michael Belshan, Annemarie Shibata, Heather Vincent, Caroline E Baker, William O Thayer, Guenter Kraus, Sophie Lachaud-Durand, Peter Williams, Christopher J Destache, J Victor Garcia
Publikováno v:
PLoS Pathogens, Vol 11, Iss 8, p e1005075 (2015)
Vaginal HIV transmission accounts for the majority of new infections worldwide. Currently, multiple efforts to prevent HIV transmission are based on pre-exposure prophylaxis with various antiretroviral drugs. Here, we describe two novel nanoformulati
Externí odkaz:
https://doaj.org/article/e298246364c3454ab7986fa42d022312
Autor:
Marc Nischang, Roger Sutmuller, Gustavo Gers-Huber, Annette Audigé, Duo Li, Mary-Aude Rochat, Stefan Baenziger, Ursula Hofer, Erika Schlaepfer, Stephan Regenass, Katie Amssoms, Bart Stoops, Anja Van Cauwenberge, Daniel Boden, Guenter Kraus, Roberto F Speck
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e38853 (2012)
BACKGROUND: Humanized mice generate a lymphoid system of human origin subsequent to transplantation of human CD34+ cells and thus are highly susceptible to HIV infection. Here we examined the efficacy of antiretroviral treatment (ART) when added to f
Externí odkaz:
https://doaj.org/article/a0eef2ffb6d34bd1a4372d297ec17cbd
Autor:
Guenter Kraus, Jeroen A. Verwoerd, Katie Amssoms, Ben De Clerck, Henderik W. Frijlink, Wouter L. J. Hinrichs, Lieven Baert, Ellen Van Gulck, Max Beugeling, Dirk Roymans, Freek Cox
Publikováno v:
Pharmaceutics
Pharmaceutics, 11(10):510. MDPI AG
Volume 11
Issue 10
Pharmaceutics, Vol 11, Iss 10, p 510 (2019)
Pharmaceutics, 11(10):510. MDPI AG
Volume 11
Issue 10
Pharmaceutics, Vol 11, Iss 10, p 510 (2019)
Currently, there is an increasing interest to apply pre-fusion (pre-F) protein of respiratory syncytial virus (RSV) as antigen for the development of a subunit vaccine. A pre-F-containing powder would increase the flexibility regarding the route of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4722e37b0ac7749f596d705f589f8903
https://pubmed.ncbi.nlm.nih.gov/31623333
https://pubmed.ncbi.nlm.nih.gov/31623333
Autor:
Guenter Kraus, Philip A. Born, Kenny Simmen, Lieven Baert, Katie Amssoms, Ben De Clerck, Max Beugeling, Roger Paulus Maria Sutmuller, Ellen Van Gulck, Henderik W. Frijlink, Wouter L. J. Hinrichs, Niels Grasmeijer
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0202961 (2018)
PLoS ONE, 13(8):0202961. PUBLIC LIBRARY SCIENCE
PLoS ONE, 13(8):0202961. PUBLIC LIBRARY SCIENCE
A single-injection vaccine formulation that provides for both a prime and a boost immunization would have various advantages over a multiple-injection regime. For such a vaccine formulation, it is essential that the booster dose is released after a c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3317e98f4d0816505cb1bb74632ec757
https://doi.org/10.1371/journal.pone.0202961
https://doi.org/10.1371/journal.pone.0202961
Autor:
Fred Stappers, Alfons Wouters, Koen Iterbeke, Francois Marc Karel Jozef, Guenter Kraus, Piet Wigerinck, Laurent Schueller, Lieven Baert, Pieter Van Remoortere, Esther Dina Guido Basstanie, Gerben Albert Eleutherius Van 'T Klooster, Willy Maria Albert Carlo Dries, Jan Rosier, Paul Stevens
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 72:502-508
Long-acting parenteral formulations of antiretrovirals could facilitate maintenance and prophylactic treatment in HIV. Using the poorly water- and oil-soluble non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC278 (rilpivirine) as base or hydr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21ff3bdc25a0c1fa3af869d274846cdc
https://doi.org/10.1016/j.ejpb.2009.03.006
https://doi.org/10.1016/j.ejpb.2009.03.006
Autor:
Guenter Kraus, Johan Vingerhoets, Lotke Tambuyzer, Pierre Lecocq, Hilde Azijn, Marie-Pierre de Béthune, Laurence T. Rimsky, Gaston Picchio
Publikováno v:
Antiviral Therapy. 14:103-109
Background Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are an important component of antiretroviral therapy for HIV type-1 (HIV-1)-infected patients. Development of NNRTI resistance can lead to treatment failure and is conferred by the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::682287473a9a9c224f233c685843416c
https://doi.org/10.1177/135965350901400114
https://doi.org/10.1177/135965350901400114
Dieses Buch beantwortet die 100 dringlichsten Fragen, die sich einem Neuling in der Apple-Welt beim ersten Kontakt mit einem Mac stellen. Durch den Aufbau im Frage-Antwort-Muster finden Sie die Lösung zu einem Problem besonders schnell und lernen we
